← FDA Drug Approvals (Drugs@FDA)
RILUZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DAITO PHARMS CO LTD · Approved 2018-10-16
Drug application
- FDA Application #
ANDA204430- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RILUZOLE
- Generic name
- Riluzole
- Active ingredients
- RILUZOLE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- DAITO PHARMS CO LTD
- First approval
- 2018-10-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown